SG Americas Securities
SRRA

SG Americas Securities’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

SG Americas Securities’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,230
Closed -$453K – 3710
2022
Q2 		$453K Buy
+8,230
New +$432K ﹤0.01% 2042

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

SG Americas Securities's SRRA Position: Q3 2022 in Review

SG Americas Securities sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 8,230 shares — an estimated $453K sold.

SG Americas Securities first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $453K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • SG Americas Securities reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • SG Americas Securities sold 8,230 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $453K.
  • SG Americas Securities first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • SG Americas Securities's Sierra Oncology, Inc. Common Stock position peaked at $453K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on SG Americas Securities's 13F filing for Q3 2022, filed 31 Oct 2022.